Therapeutic plasma exchange in neurology: 2012

Irene Cortese, David Cornblath

Research output: Contribution to journalArticle

Abstract

In treating neuroimmunological diseases, neurologists have a number of different drugs to choose from ranging from corticosteroids to IVIg to more specific cell based therapies, the latter most frequently from the world of oncology. In some diseases, therapeutic plasma exchange, a procedure rather than a drug, is used. The most obvious advantage of therapeutic plasma exchange is the usually rapid onset of action presumably due to removal of pathogenic auto-antibodies. In some diseases, a single course of therapeutic plasma exchange is used while in others prolonged treatment with therapeutic plasma exchange is used. This article will review the use of therapeutic plasma exchange in neurology and will draw heavily upon recent consensus statements from the American Society for Apheresis and the American Academy of Neurology and by Cochrane reviews. J. Clin. Apheresis 28:16-19, 2013. © 2013 Wiley Periodicals, Inc.

Original languageEnglish (US)
Pages (from-to)16-19
Number of pages4
JournalJournal of Clinical Apheresis
Volume28
Issue number1
DOIs
StatePublished - Feb 2013

Fingerprint

Plasma Exchange
Neurology
Therapeutics
Blood Component Removal
Therapeutic Uses
Cell- and Tissue-Based Therapy
Pharmaceutical Preparations
Adrenal Cortex Hormones
Antibodies

Keywords

  • apheresis
  • CIDP
  • Guillain-Barré syndrome
  • myasthenia gravis
  • neurologic indications
  • plasmapheresis
  • therapeutic plasma exchange

ASJC Scopus subject areas

  • Hematology

Cite this

Therapeutic plasma exchange in neurology : 2012. / Cortese, Irene; Cornblath, David.

In: Journal of Clinical Apheresis, Vol. 28, No. 1, 02.2013, p. 16-19.

Research output: Contribution to journalArticle

@article{6daf2b4897ea44f182586e247c917ed6,
title = "Therapeutic plasma exchange in neurology: 2012",
abstract = "In treating neuroimmunological diseases, neurologists have a number of different drugs to choose from ranging from corticosteroids to IVIg to more specific cell based therapies, the latter most frequently from the world of oncology. In some diseases, therapeutic plasma exchange, a procedure rather than a drug, is used. The most obvious advantage of therapeutic plasma exchange is the usually rapid onset of action presumably due to removal of pathogenic auto-antibodies. In some diseases, a single course of therapeutic plasma exchange is used while in others prolonged treatment with therapeutic plasma exchange is used. This article will review the use of therapeutic plasma exchange in neurology and will draw heavily upon recent consensus statements from the American Society for Apheresis and the American Academy of Neurology and by Cochrane reviews. J. Clin. Apheresis 28:16-19, 2013. {\circledC} 2013 Wiley Periodicals, Inc.",
keywords = "apheresis, CIDP, Guillain-Barr{\'e} syndrome, myasthenia gravis, neurologic indications, plasmapheresis, therapeutic plasma exchange",
author = "Irene Cortese and David Cornblath",
year = "2013",
month = "2",
doi = "10.1002/jca.21266",
language = "English (US)",
volume = "28",
pages = "16--19",
journal = "Journal of Clinical Apheresis",
issn = "0733-2459",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Therapeutic plasma exchange in neurology

T2 - 2012

AU - Cortese, Irene

AU - Cornblath, David

PY - 2013/2

Y1 - 2013/2

N2 - In treating neuroimmunological diseases, neurologists have a number of different drugs to choose from ranging from corticosteroids to IVIg to more specific cell based therapies, the latter most frequently from the world of oncology. In some diseases, therapeutic plasma exchange, a procedure rather than a drug, is used. The most obvious advantage of therapeutic plasma exchange is the usually rapid onset of action presumably due to removal of pathogenic auto-antibodies. In some diseases, a single course of therapeutic plasma exchange is used while in others prolonged treatment with therapeutic plasma exchange is used. This article will review the use of therapeutic plasma exchange in neurology and will draw heavily upon recent consensus statements from the American Society for Apheresis and the American Academy of Neurology and by Cochrane reviews. J. Clin. Apheresis 28:16-19, 2013. © 2013 Wiley Periodicals, Inc.

AB - In treating neuroimmunological diseases, neurologists have a number of different drugs to choose from ranging from corticosteroids to IVIg to more specific cell based therapies, the latter most frequently from the world of oncology. In some diseases, therapeutic plasma exchange, a procedure rather than a drug, is used. The most obvious advantage of therapeutic plasma exchange is the usually rapid onset of action presumably due to removal of pathogenic auto-antibodies. In some diseases, a single course of therapeutic plasma exchange is used while in others prolonged treatment with therapeutic plasma exchange is used. This article will review the use of therapeutic plasma exchange in neurology and will draw heavily upon recent consensus statements from the American Society for Apheresis and the American Academy of Neurology and by Cochrane reviews. J. Clin. Apheresis 28:16-19, 2013. © 2013 Wiley Periodicals, Inc.

KW - apheresis

KW - CIDP

KW - Guillain-Barré syndrome

KW - myasthenia gravis

KW - neurologic indications

KW - plasmapheresis

KW - therapeutic plasma exchange

UR - http://www.scopus.com/inward/record.url?scp=84874023756&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874023756&partnerID=8YFLogxK

U2 - 10.1002/jca.21266

DO - 10.1002/jca.21266

M3 - Article

C2 - 23420591

AN - SCOPUS:84874023756

VL - 28

SP - 16

EP - 19

JO - Journal of Clinical Apheresis

JF - Journal of Clinical Apheresis

SN - 0733-2459

IS - 1

ER -